This book shares the latest research and practice-oriented findings in medical sciences with a wide audience.

It addresses a range of contemporary issues, often unresolved or contentious, across various medical fields, including advances in the management of hemorrhagic brain stroke. It also discusses metastatic renal cell carcinoma a global scourge with an extremely poor long-term survival prognosis, the course and sequelae of renal cell carcinoma, as well as advances in targeted molecular therapy with sunitinib, a receptor tyrosine kinase inhibitor. Further, it examines the molecular targeting of proliferative signaling of the epidermal growth factor receptor in the first-line treatment of patients with metastatic non-small-cell lung cancer. Other articles cover clearance of toxins in hemodialyzed patients; the search for diagnostic and therapeutic markers in the connective tissue disease scleroderma; obesity linked to inappropriate dietary habit; clinical problems related to the diagnosis of sensitization to fungi and its role in asthma; and reasons for the perilous trend of avoiding basic vaccinations in children. Lastly, the book explores the rapid developments in e-health technologies that increase access to health services, particularly for the elderly.

The book is intended for clinical specialists, researchers, and all allied health professionals from various fields.

Describes novel applications of medical science Focuses on discoveries and advanced developments in health sciences Presents examples of innovative clinical practice

Inhalt

Advancements in Managing Intracerebral Hemorrhage: Transition from Nihilism to Optimism.- Mandibular Advancement Devices in Patients with Symptoms of Obstructive Sleep Apnea: A Review.- Online Health Technologies and Mobile Devices: Attitudes, Needs and Future.- Radiological Response and Neutrophil-to-Lymphocyte Ratio as Predictive Factors for Progression-Free and Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib.- Plasminogen Activator Inhibitor Type 1 in Blood at Onset of Chemotherapy Unfavorably Affects Survival in Primary Ovarian Cancer.- Sialidase Attenuates Epidermal Growth Factor Response and Abolishes Antiproliferative Effects of Erlotinib in A549Alveolar Epithelial Cells.- Systemic Sclerosis and Serum Content of Transforming Growth Factor.- Protein-Bound Solute Clearance during Hemodialysis.- Mold Sensitization in Asthmatic and Non-Asthmatic Subjects Diagnosed with Extract-Based versus Component-BasedAllergens.- Fructose Consumption and Lipid Metabolism in Obese Children and Adolescents.- Vaccination against Measles, Mumps, and Rubella in the Light of Current Epidemic Threats: Unjustified Postponement.- Variability of Dry-Eye Disease Following Removal of Lacrimal Glands in Rats.